Triple hormone receptor agonist
Activates GLP-1, GIP, and glucagon receptors, delivering broader metabolic benefits than single-agonist drugs.
Significant weight loss potential
Clinical trials show average body weight reductions of up to 24% over time, making it one of the most potent agents for fat loss.
Appetite suppression
Strongly reduces hunger and food intake, supporting sustained calorie deficit without extreme dieting.
Enhanced insulin sensitivity
Improves glucose metabolism, lowers fasting insulin, and supports better blood sugar control.
Reduction in visceral and liver fat
Effectively targets deep abdominal fat and reduces liver fat associated with metabolic disorders.
Improves lipid profiles
Associated with reductions in triglycerides and other harmful blood fats.
Increases energy expenditure
Through glucagon receptor activity, it helps burn more calories at rest and promotes fat oxidation.
Potential muscle mass preservation
Primarily reduces fat while helping retain lean body mass during weight loss.
GLP-3 R 15mg is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor. This extra receptor interaction enhances glucagon production, thereby increasing basal metabolism. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists.
Product Care:
Store in a cool, dry place away from light. If reconstituted, please refrigerate. For long term storage, freezing at -20°C is recommended to maintain integrity.
Product Note:
All products are shipped in lyophilized or powder form and must be reconstituted to a liquid for research and testing. We are unable to provide any dosing instructions, however all products should be considered pharmaceutical grade.